Vitamin B12 status of infants aged 4–12 months with neurodevelopmental abnormalities without any obvious cause and their outcome at 6 months after treatment: A prospective pilot cohort study
Nutrition and Health · 29.10.2026
DOI: 10.1177/02601060261503103 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nutrition and Health, online erschienen am 29.10.2026. Verfasst von Kumaresan Gokulpriya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, JIPMER, Puducherry, India. Die Arbeit nennt 27 Literaturangaben. Gefördert von: JIPMER, Puducherry.
Abstract (Originalsprache)
Background
Developmental disabilities affect millions of children globally, and vitamin B12 deficiency is a potential cause, particularly in Indian infants.
Aim
This prospective pilot cohort study evaluated vitamin B12 status in infants with neurodevelopmental abnormalities and feeding difficulties and assessed the impact of B12 treatment on their developmental outcomes.
Methods
Forty infants aged 4–12 months with neurodevelopmental disabilities or feeding difficulties without an obvious cause from the history and clinical examination were enrolled. Infants were divided into two groups based on their serum vitamin B12 levels: deficient and sufficient. All infants received supportive therapy (early stimulation, nutritional counseling, and physiotherapy). Additionally, infants with vitamin B12 deficiency received B12 treatment. Improvements in clinical features, anthropometric status, and developmental scores (using the Developmental Assessment Scale for Indian Infants) were assessed at baseline and after 6 months and compared within the groups. Summary Vitamin B12 deficiency was found in 62.5% ( n = 25) of the infants. Following the intervention, the deficient group showed significant improvements in clinical features, anthropometric measures (weight-for-age, length-for-age, both p < 0.001; and weight-for-length, p = 0.001), as well as developmental assessments (motor and mental quotients, p = 0.011 and p < 0.001, respectively) compared to their baseline values. These improvements were more pronounced in the vitamin B12-deficient group and not in the vitamin B12-sufficient group. Vitamin B12 deficiency may be a common and potentially preventable contributor to developmental delay in this population, underscoring the importance of early identification and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, JIPMER, Puducherry, India.
- Department of Biochemistry, JIPMER, Puducherry, India.
ORCID-Profile: Dhandapany Gunasekaran, Sharbari Basu
Förderung
- JIPMER, Puducherry
Zitieren
APA
Gokulpriya, K., Gunasekaran, D., Basu, S., & Mondal, N. (2026). Vitamin B12 status of infants aged 4–12 months with neurodevelopmental abnormalities without any obvious cause and their outcome at 6 months after treatment: A prospective pilot cohort study. Nutrition and Health. https://doi.org/10.1177/02601060261503103
Vancouver
Gokulpriya K, Gunasekaran D, Basu S, Mondal N. Vitamin B12 status of infants aged 4–12 months with neurodevelopmental abnormalities without any obvious cause and their outcome at 6 months after treatment: A prospective pilot cohort study. Nutrition and Health. 2026. doi:10.1177/02601060261503103
BibTeX
@article{Gokulpriya2026,
author = {Gokulpriya, Kumaresan and Gunasekaran, Dhandapany and Basu, Sharbari and Mondal, Nivedita},
title = {Vitamin B12 status of infants aged 4–12 months with neurodevelopmental abnormalities without any obvious cause and their outcome at 6 months after treatment: A prospective pilot cohort study},
journal = {Nutrition and Health},
year = {2026},
doi = {10.1177/02601060261503103}
}
EUVIMED